miR-16 has been demonstrated to inhibit cell invasion and metastasis via inversely regulating Twist1 in some cancers such as gastric cancer and non-small cell lung carcinoma (NSCLC) [25, 26]. Here, TWIST1 is linked to gastric cancer.